John Owens MBA
About John Owens MBA
John Owens MBA is the Vice President of the Trade and Institutional Account Team at Alkermes in Waltham, Massachusetts, with a background in finance and marketing.
Company
John Owens currently works at Alkermes in Waltham, Massachusetts, United States. At Alkermes, he serves as the Vice President of the Trade and Institutional Account Team. Alkermes is a biopharmaceutical company focused on developing innovative treatments for serious diseases. John’s role involves optimizing market access and reimbursement strategies for the company's product portfolio across multiple channels.
Title
John Owens holds the position of Vice President of the Trade and Institutional Account Team at Alkermes. His responsibilities include leading negotiations with key stakeholders such as payers, distributors, providers, and advocacy groups to ensure favorable contracts and agreements. His focus is on optimizing market access and reimbursement for Alkermes’ products.
Education and Expertise
John Owens received his MBA in Finance from the Quinlan School of Business at Loyola University Chicago. He also holds a B.S. in Marketing from the University of Scranton. Additionally, he completed his high school education at Donovan Catholic High School. John has extensive experience in launching and growing brands, particularly in the oncology, CNS, addiction, and urology therapeutic areas.
Professional Background
Previously, John Owens worked as Vice President of the Trade and Corporate Account Team at Alkermes from 2018 to 2021. Prior to Alkermes, he held several positions at Astellas Pharma US, including Senior Director Channel Account Team, National Vice President Key Account Management, and Senior Director Institutional and Oncology Account Team. He also served as Managed Markets Product Manager at Schering-Plough Pharmaceuticals.
Focused on Market Access and Reimbursement
John Owens is dedicated to optimizing market access and reimbursement for Alkermes' products across various channels and segments. His mission-driven approach leverages his skills and expertise to make a significant impact on the lives of people living with serious and complex diseases. His approach involves collaboration with market access customers to achieve these goals.